These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 9009257

  • 1. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement.
    Nagata T, Higashigawa M, Nagai M, Zhang XL, Azuma E, Komada Y, Sakurai M.
    Leuk Res; 1996; 20(11-12):983-5. PubMed ID: 9009257
    [Abstract] [Full Text] [Related]

  • 2. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
    Handa H, Motohashi S, Isozumi K, Komatsumoto S, Nara M.
    Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acute undifferentiated leukemia with an unusual CD7+ CD56+ CD33+ immunophenotype of NK progenitors.
    Reuss-Borst MA, Jaschonek K, Müller CA.
    Leukemia; 1996 May; 10(5):923-4. PubMed ID: 8656693
    [No Abstract] [Full Text] [Related]

  • 5. Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: a case report.
    Hashimoto S, Toba K, Aoki S, Tsuchiyama J, Tsukada N, Takahashi H, Takahashi M, Aizawa Y.
    Leuk Res; 2002 Feb; 26(2):215-9. PubMed ID: 11755472
    [Abstract] [Full Text] [Related]

  • 6. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F, Chen Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [Abstract] [Full Text] [Related]

  • 7. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
    Yang X, Wasserman PG, Bhargava A, Iqbal U, Ragnauth S, Fuchs A.
    Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
    [Abstract] [Full Text] [Related]

  • 8. The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture.
    Miller JS, Verfaillie C, McGlave P.
    Blood; 1992 Nov 01; 80(9):2182-7. PubMed ID: 1384796
    [Abstract] [Full Text] [Related]

  • 9. Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic progenitor cells.
    Pierelli L, Teofili L, Menichella G, Rumi C, Paoloni A, Iovino S, Puggioni PL, Leone G, Bizzi B.
    Br J Haematol; 1993 May 01; 84(1):24-30. PubMed ID: 7687858
    [Abstract] [Full Text] [Related]

  • 10. Five Chinese pediatric patients with leukemias possibly arising from immature natural killer cells: clinical features and courses.
    Guan XQ, Xu L, Ke ZY, Huang LB, Zhang XL, Zhang YC, Luo XQ.
    Pediatr Hematol Oncol; 2011 Apr 01; 28(3):187-93. PubMed ID: 21271777
    [Abstract] [Full Text] [Related]

  • 11. Chronic myelomonocytic leukemia derived from a possible common progenitor of monocytes and natural killer cells.
    Kojima H, Bai A, Mukai HY, Hori M, Komeno T, Hasegawa Y, Ninomiya H, Mori N, Nagasawa T.
    Leuk Lymphoma; 2000 May 01; 37(5-6):617-21. PubMed ID: 11042523
    [Abstract] [Full Text] [Related]

  • 12. T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia.
    Mantadakis E, Danilatou V, Stiakaki E, Paterakis G, Papadhimitriou S, Kalmanti M.
    Pediatr Blood Cancer; 2007 Mar 01; 48(3):354-7. PubMed ID: 16206214
    [Abstract] [Full Text] [Related]

  • 13. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
    Suzuki R, Yamamoto K, Seto M, Kagami Y, Ogura M, Yatabe Y, Suchi T, Kodera Y, Morishima Y, Takahashi T, Saito H, Ueda R, Nakamura S.
    Blood; 1997 Sep 15; 90(6):2417-28. PubMed ID: 9310493
    [Abstract] [Full Text] [Related]

  • 14. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
    Verfaillie CM, Miller JS.
    Blood; 1994 Sep 01; 84(5):1442-9. PubMed ID: 7520771
    [Abstract] [Full Text] [Related]

  • 15. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T, Kimura N, Sawada H, Suematsu E, Nagano M, Akiyoshi T, Motomura S, Kikuchi M, Nishimura J, Tamura K.
    Intern Med; 1999 Jul 01; 38(7):547-55. PubMed ID: 10435360
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group.
    Bradstock K, Matthews J, Benson E, Page F, Bishop J.
    Blood; 1994 Aug 15; 84(4):1220-5. PubMed ID: 8049437
    [Abstract] [Full Text] [Related]

  • 17. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.
    Ai Zheng; 2007 Apr 15; 26(4):418-22. PubMed ID: 17430665
    [Abstract] [Full Text] [Related]

  • 18. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
    Yamada O, Ichikawa M, Okamoto T, Park C, Motoji T, Mizoguchi H, Shibuya A.
    Br J Haematol; 2001 Apr 15; 113(1):153-60. PubMed ID: 11328295
    [Abstract] [Full Text] [Related]

  • 19. Transient myeloproliferative disorder with a CD7+ and CD56+ myeloid/natural killer cell precursor phenotype in a newborn.
    Svaldi M, Moroder W, Messner H, Battisti L, Venturi R, Coser P, Mitterer M.
    J Pediatr Hematol Oncol; 2002 Apr 15; 24(5):394-6. PubMed ID: 12142790
    [Abstract] [Full Text] [Related]

  • 20. CD7 expression on CD34+ cells from chronic myeloid leukaemia in chronic phase.
    Martín-Henao GA, Quiroga R, Sureda A, García J.
    Am J Hematol; 1999 Jul 15; 61(3):178-86. PubMed ID: 10398310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.